These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9297531)

  • 1. Delivery of antigens to the MHC class I pathway using bacterial toxins.
    Goletz TJ; Klimpel KR; Leppla SH; Keith JM; Berzofsky JA
    Hum Immunol; 1997 May; 54(2):129-36. PubMed ID: 9297531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.
    Goletz TJ; Klimpel KR; Arora N; Leppla SH; Keith JM; Berzofsky JA
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12059-64. PubMed ID: 9342362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
    Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
    Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified anthrax fusion proteins deliver HIV antigens through MHC Class I and II pathways.
    McEvers K; Elrefaei M; Norris P; Deeks S; Martin J; Lu Y; Cao H
    Vaccine; 2005 Jul; 23(32):4128-35. PubMed ID: 15964481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways.
    Lippolis JD; Denis-Mize KS; Brinckerhoff LH; Slingluff CL; Galloway DR; Engelhard VH
    Cell Immunol; 2000 Aug; 203(2):75-83. PubMed ID: 11006005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of an exogenous antigen by major histocompatibility complex class I molecules.
    Ulmer JB; Donnelly JJ; Liu MA
    Eur J Immunol; 1994 Jul; 24(7):1590-6. PubMed ID: 8026520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin.
    Lee RS; Tartour E; van der Bruggen P; Vantomme V; Joyeux I; Goud B; Fridman WH; Johannes L
    Eur J Immunol; 1998 Sep; 28(9):2726-37. PubMed ID: 9754560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol.
    Cao H; Agrawal D; Kushner N; Touzjian N; Essex M; Lu Y
    J Infect Dis; 2002 Jan; 185(2):244-51. PubMed ID: 11807699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
    Donnelly JJ; Ulmer JB; Hawe LA; Friedman A; Shi XP; Leander KR; Shiver JW; Oliff AI; Martinez D; Montgomery D
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3530-4. PubMed ID: 7682709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel protein toxin-based strategy for development of cytotoxic T lymphocyte vaccines.
    Wiedłocha A
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):341-6. PubMed ID: 9883312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.
    Noakes KL; Teisserenc HT; Lord JM; Dunbar PR; Cerundolo V; Roberts LM
    FEBS Lett; 1999 Jun; 453(1-2):95-9. PubMed ID: 10403383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
    Wolf BJ; Princiotta MF
    Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
    Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
    Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence.
    Szalay G; Hess J; Kaufmann SH
    Eur J Immunol; 1994 Jul; 24(7):1471-7. PubMed ID: 8026511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of exogenous protein antigens to a novel endosomal processing pathway for class I-restricted presentation.
    Schirmbeck R; Reimann J
    Behring Inst Mitt; 1994 Dec; (95):14-22. PubMed ID: 7755505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes.
    Harding CV; Song R; Griffin J; France J; Wick MJ; Pfeifer JD; Geuze HJ
    Infect Agents Dis; 1995 Mar; 4(1):1-12. PubMed ID: 7728352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tools for antigen delivery to the MHC class I pathway.
    Morón G; Dadaglio G; Leclerc C
    Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.